CXCL10 and inflammatory bowel disease: Anti-CXCL10 monoclonal antibodies have implications in infectious disease, chronic inflammatory, and autoimmune disease therapeutics and attenuate murine inflammatory bowel disease and murine AIDS colitis [56].